Jimmy Lee, MBBS, MMed, MCI

  • 8Articles
  • 30.1KReads
  • 2011–2023Active
  • 25Collaborators
  • 87Citations

About

Jimmy Lee, MBBS, MMed, MCI, is affiliated with the Research Division and Department of Psychosis at the Institute of Mental Health, Singapore, as well as the Lee Kong Chian School of Medicine, Nanyang Technological University. Since 2011, Lee has published extensively on schizophrenia, schizoaffective disorders, mood disorders, and psychiatric genetics. His work includes studies on clozapine use, pharmacokinetics, clinical outcomes, and genetic influences on neurocognitive and neuroanatomical phenotypes in schizophrenia. Frequent collaborators include Gary Remington, Gagan Fervaha, Hiroyoshi Takeuchi, Amaal Bhaloo, and George Foussias.

Publications

JCP
Clozapine Delay and Schizophrenia Outcomes
Original Research

Clozapine Delay and Schizophrenia Outcomes

August 23, 2023

Clozapine is the drug of choice for treatment-resistant schizophrenia, but delays in initiation and underutilization may hinder its effectiveness. This study examined whether delay in clozapine initiation led to...
, , , et al
JCP
Clozapine Use in Singapore and Hong Kong
Original Research

Clozapine Use in Singapore and Hong Kong

May 18, 2022

This survey investigated clinicians’ use of clozapine for schizophrenia, beliefs about its effectiveness, and concerns regarding this medication.
, ,
JCP
Article

Two Strategies for Switching to Clozapine

February 22, 2017

What's the best way to switch to clozapine in patients with treatment-resistant schizophrenia? Do you worry that efficacy and tolerability will be compromised? This pilot, double-blind RCT addresses your...
, , , et al
JCP
Article

Quantifying Intraindividual Variations in Plasma Clozapine Levels: A Population Pharmacokinetic Approach

May 25, 2016

Clozapine is the most effective antipsychotic used in the treatment of refractory schizophrenia. But how do factors like smoking and caffeine intake affect plasma clozapine levels? The authors of...
, , , et al
JCP
Letter to the Editor

Drs Lee and Remington Reply

April 27, 2016

,
JCP
Original Research

Clozapine and Anemia: A 2-Year Follow-Up Study

December 23, 2015

, , , et al
JCP
Original Research

Determinants of Patient-Rated and Clinician-Rated Illness Severity in Schizophrenia

July 22, 2015

, , , et al
JCP
Original Research

ARVCF Genetic Influences on Neurocognitive and Neuroanatomical Intermediate Phenotypes in Chinese Patients With Schizophrenia

October 18, 2011

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe